Russia Escalates Ukraine Conflict Threatens Additional Strikes on Kyiv Urges Foreign Nationals to Depart
Wipros Rs 15000 Crore Share Buyback at 23 Premium Key Details and Market Implications
Indias Education Loans Surge 15 to Hit DecadeHigh 858 Lakh Crore in FY26
Key Economic Data and Corporate Earnings to Watch This Week
Jim Cramer Analyzes NVIDIAs Latest Quarterly Performance Key Insights for Investors
Applied Digital Signs Major Hyperscaler Lease at Polaris Forge 3 Campus What It Means for Growth
ColgatePalmolive Q1 2026 Earnings EPS Slightly Below Estimates Amid Stable Operations
CLDX Q1 2026 Earnings Slight EPS Miss as DevelopmentStage Biotech Continues NoRevenue Phase
Bank of Marin Bancorp BMRC Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Landscape
AA Q1 2026 Earnings EPS Misses Estimates Shares Climb on Strategic Optimism
NCTY Q1 2012 Earnings Narrower Loss Beats Estimates but Stock Slides
TGT Q1 2026 Earnings EPS Surprises to the Upside Stock Reacts Positively
Chiron Real Estate Inc XRN Holds Steady Near 3742 as Support and Resistance Levels Remain Key
GECCH Notes Dip 16 Support Levels and Yield Dynamics in Focus
Compass Inc COMP Edges Higher Navigating Support and Resistance Levels
RZC Holds Steady Near Par as Investors Assess FixedRate Reset Features
Columbus Circle Capital Corp II CMII Holds Steady Near 991 Amid Flat Trading
SpaceX IPO Filing Draws Market Attention KraneShares AGIX Offers Indirect Space Exposure
CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline
InflaRx NV IFRX Surges 75 as Shares Test Key Resistance Level
abrdn FCO Stock Down 077 Support Test at 244 20260515
AI Accelerates New Business Formation Gen Z Entrepreneurs Lead the Charge Gusto Report
Elon Musk Vows to Appeal After Jury Ruling Against Him in OpenAI Trial
Anika ANIK Q1 2026 Earnings Surprise EPS 027 Up Significant
Why Vijay Kedia Suggests Indias Tourism Sector Could Emerge as a TrillionDollar Opportunity
Kinross Gold Continues Capital Return Strategy While Major Growth Projects Move Forward
MIRA Pharmaceuticals MIRA Q3 2025 Earnings Why the Beat Matters